SPRY4 and colorectal carcinoma: SPRY4 overexpression significantly inhibits colon cancer cell proliferation by suppressing human colorectal cancer (CRC) cell viability and impeding cancer cell colony formation, which may be achieved by regulating the EZH2/MDM2/p53 pathway (8).